Literature DB >> 11451632

Filter extrusion of liposomes using different devices: comparison of liposome size, encapsulation efficiency, and process characteristics.

N Berger1, A Sachse, J Bender, R Schubert, M Brandl.   

Abstract

Liposomes were prepared by stepwise extrusion through 5, 1, 0.4, 0.2, 0.1 and 0.05 microm pore sizes using two different filter-extruders, the continuous high pressure device Dispex Maximator (CE) or alternatively the discontinuous Avestin LiposoFast (DE). The liposome dispersions obtained were compared in terms of particle size, lamellarity and encapsulation efficiency of calcein. The liposomes were smaller with CE than DE at all stages due to higher flow rates and pressure drops, except for final filter pore size (0.05 microm) where both preparations had similar sizes. The particle size analysis technique itself had a strong influence on the liposome sizes measured. For bigger liposomes (extruded through 0.4 microm filters) the Nicomp 370 revealed bigger volume-based mean particle sizes along with more stringent differences between volume-based and number-based diameters than the Malvern Zetasizer. In contrast, for small liposomes extruded through 0.05 microm filters, similar liposome sizes were found no matter which of the two PCS techniques or cryo-transmission electron microscopy was used. In congruence to the liposome sizes measured, encapsulation efficiencies were smaller for CE than DE at all filter stages except the final (0.05 microm). No lipid loss occurred and lyso-phosphatidylcholine formation was negligible irrespective of which extrusion technique was used.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11451632     DOI: 10.1016/s0378-5173(01)00721-9

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  32 in total

1.  Size-induced enhancement of chemical exchange saturation transfer (CEST) contrast in liposomes.

Authors:  Jason M Zhao; Yah-el Har-el; Michael T McMahon; Jinyuan Zhou; A Dean Sherry; George Sgouros; Jeff W M Bulte; Peter C M van Zijl
Journal:  J Am Chem Soc       Date:  2008-03-25       Impact factor: 15.419

Review 2.  mRNA vaccine delivery using lipid nanoparticles.

Authors:  Andreas M Reichmuth; Matthias A Oberli; Ana Jaklenec; Robert Langer; Daniel Blankschtein
Journal:  Ther Deliv       Date:  2016

3.  Influence of cholesterol on liposome stability and on in vitro drug release.

Authors:  Maria-Lucia Briuglia; Chiara Rotella; Amber McFarlane; Dimitrios A Lamprou
Journal:  Drug Deliv Transl Res       Date:  2015-06       Impact factor: 4.617

4.  Development and optimization of nanosomal formulations for siRNA delivery to the liver.

Authors:  Anup K Kundu; Partha K Chandra; Sidhartha Hazari; Yashoda V Pramar; Srikanta Dash; Tarun K Mandal
Journal:  Eur J Pharm Biopharm       Date:  2011-11-18       Impact factor: 5.571

5.  Effect of Erythrodiol, A Natural Pentacyclic Triterpene from Olive Oil, on the Lipid Membrane Properties.

Authors:  Lamice Habib; Alia Jraij; Nathalie Khreich; Catherine Charcosset; Hélène Greige-Gerges
Journal:  J Membr Biol       Date:  2015-07-04       Impact factor: 1.843

6.  A novel nested liposome drug delivery vehicle capable of ultrasound triggered release of its payload.

Authors:  Stuart Ibsen; Michael Benchimol; Dmitri Simberg; Carolyn Schutt; Jason Steiner; Sadik Esener
Journal:  J Control Release       Date:  2011-07-02       Impact factor: 9.776

7.  Long-circulating liposomes radiolabeled with [18F]fluorodipalmitin ([18F]FDP).

Authors:  Jan Marik; Michaelann S Tartis; Hua Zhang; Jennifer Y Fung; Azadeh Kheirolomoom; Julie L Sutcliffe; Katherine W Ferrara
Journal:  Nucl Med Biol       Date:  2007-02       Impact factor: 2.408

8.  Comparison of the effects of antibody-coated liposomes, IVIG, and anti-RBC immunotherapy in a murine model of passive chronic immune thrombocytopenia.

Authors:  Rong Deng; Joseph P Balthasar
Journal:  Blood       Date:  2006-11-28       Impact factor: 22.113

9.  Glutathione-responsive nano-transporter-mediated siRNA delivery: silencing the mRNA expression of Ras.

Authors:  C George Priya Doss; S Debottam; C Debajyoti
Journal:  Protoplasma       Date:  2012-09-12       Impact factor: 3.356

10.  A platelet-mimetic paradigm for metastasis-targeted nanomedicine platforms.

Authors:  Christa L Modery-Pawlowski; Alyssa M Master; Victor Pan; Gregory P Howard; Anirban Sen Gupta
Journal:  Biomacromolecules       Date:  2013-02-14       Impact factor: 6.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.